U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
Original article: https://www.reviewjournal.com/news/nation-and-world/fda-delaying-decision-on-moderna-shot-for-adolescents-2469953/
